TIME
If caught early, the skin cancer called malignant melanoma is curable. If not, it’s almost always fatal. But a new treatment under study at the John Wayne Cancer Institute in Santa Monica, Calif., appears at least to prolong lives. Researchers injected patients with a tuberculosis vaccine mixed with melanoma cells. Result: average survival went from seven to 23 months, with some staying cancer free for eight years. The doctors warn that an approved vaccine could take a decade.
More Must-Reads from TIME
- Cybersecurity Experts Are Sounding the Alarm on DOGE
- Meet the 2025 Women of the Year
- The Harsh Truth About Disability Inclusion
- Why Do More Young Adults Have Cancer?
- Colman Domingo Leads With Radical Love
- How to Get Better at Doing Things Alone
- Michelle Zauner Stares Down the Darkness
Contact us at letters@time.com